Liraglutide 81607-0019

Product NDC

81607-0019

Manufacturer: Orbicular Pharmaceutical Technologies Private Limited
Dosage Form: Injection, Solution
Route: Subcutaneous
Product Type: Human Prescription Drug
Marketing Start: February 26, 2026
Listing Expires: December 31, 2027
Application: ANDA217234

Need to source Liraglutide? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Liraglutide	6 mg/mL

Drug Class

GLP-1 Receptor Agonist [EPC]GLP-1 Receptor Agonist [EPC]Glucagon-Like Peptide 1 [CS]

Packaging Options(2)

81607-0019-01

3 SYRINGE, PLASTIC in 1 CARTON (81607-019-01) / 3 mL in 1 SYRINGE, PLASTIC (81607-019-03)

View →

81607-0019-02

5 SYRINGE, PLASTIC in 1 CARTON (81607-019-02) / 3 mL in 1 SYRINGE, PLASTIC (81607-019-03)

View →